United States:
HHS Proposed Changes To Anti-Kickback Statute And Stark Law (Video)
To print this article, all you need is to be registered or login on Mondaq.com.
Karen Lovitch, Chair of Mintz's Health Law Practice, and
Theresa Carnegie, a Member in the Health Law Practice, discuss the
proposed changes to the Anti-Kickback Statute (AKS) and Stark Law
issued by Department of Health & Human Services (HHS) and dive
into some of the key issues.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
